Axogen (AXGN) EPS (Weighted Average and Diluted) (2010 - 2026)

Axogen's EPS (Weighted Average and Diluted) history runs 10 years deep, the most recent figure standing at -$0.38 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 375.0% year-over-year to -$0.38; the TTM figure through Mar 2026 stood at -$0.64 (down 326.67% YoY), while the FY2025 annual figure was -$0.34, down 47.83% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.38 for Q1 2026 at Axogen, down from -$0.28 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.01 in Q2 2025 to a low of -$0.38 in Q1 2026.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.13 across 5 years, with a median of -$0.1 in 2022.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 125.0% in 2025; the steepest drop was 2900.0% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.13 in 2022, then jumped by 30.77% to -$0.09 in 2023, then soared by 111.11% to $0.01 in 2024, then tumbled by 2900.0% to -$0.28 in 2025, then sank by 35.71% to -$0.38 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.38 (Q1 2026), -$0.28 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.